Molecular docking study of the acetylcholinesterase inhibition
While Alzheimer disease is the most common form of dementia, acetylcholinesterase is an interesting therapeutic target for the development of new anti-Alzheimer’s disease drugs. In order to discover potential compounds inhibiting this protein target, a molecular docking study of a similar collection...
Main Authors: | Merzoug Amina, Boucherit Hanane, Khaled Rima, Chefiri Amel, Chikhi Abdelouahab, Bensegueni Abderrahmane |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2021-03-01
|
Series: | Current Issues in Pharmacy and Medical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.2478/cipms-2021-0005 |
Similar Items
-
Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives
by: Igor A. Schepetkin, et al.
Published: (2023-04-01) -
In Silico Screening of Cinnamon (Cinnamomum burmannii) Bioactive Compounds as Acetylcholinesterase Inhibitors
by: Zatta Yumni Ihdhar Syarafina, et al.
Published: (2022-03-01) -
Synthesis, Docking Studies and Acetylcholinesterase Inhibition of Open-Chain Carbohydrate Amides
by: Maria Isabel Ismael, et al.
Published: (2022-11-01) -
In vitro acetylcholinesterase inhibition by psoralen using molecular docking and enzymatic studies
by: Gauresh Somani, et al.
Published: (2015-01-01) -
Homology modeling and ligand interaction of human trafficking protein particle complex subunit 3-like protein and its correlation with Alzheimer’s disease
by: Manoj G, et al.
Published: (2011-01-01)